Andrew Cameron | sciencenewsnet.in

Breaking News

Launch of nationwide map viewer and database aids wildfire planning and understanding of treatment effects

Scientists Gain New Insights into How Mass Is Distributed in Hadrons

MSU expert: What the history of lame-duck presidents can tell us about President Biden’s final actions

Helping Soldiers Serve on a Full Stomach

UNC’s Graduate School Waives Application Fee for Current Students and Alumni

Addressing Food Insecurity on Campus with Expanded Resources

MSU researchers receive $4M NIH grant to study dementia risks

E-Cigarette Residue Exposure in Utero Shows Lasting Effects on Immune Response

Scientists discover ‘entirely unanticipated’ role of protein netrin1 in spinal cord development

What happens if the Department of Education disappears? Expert warns how it could threaten quality, student mobility and more.

15 Nov, 2024

Johns Hopkins Medicine to Receive $21.4 Million to Advance Viability of Animal Organs for Transplants and Enable Human Clinical Trials

March 29, 2023 sarah JonasAnnouncement

As part of the worldwide effort to facilitate a research and clinical pathway toward successful xenotransplantation — the transplantation of living cells, tissues and organs from one species to another — two Johns Hopkins Medicine surgeons, Kazuhiko Yamada, M.D., Ph.D., and Andrew Cameron, M.D., Ph.D., will receive a total of $21.4 million in funding over the next two years under two sponsored research agreements with biotechnology company United Therapeutics Corporation.